Psilocybin Mushrooms: Effects on the Brain, Risks, and Therapeutic Potential
Psilocybin (from Psilocybe mushrooms) is metabolized to psilocin, a serotonin 5-HT2A receptor agonist. This alters perception, mood, and cognition.
Acute Effects
- Visual and auditory hallucinations (patterns, colors, sounds)
- Altered sense of time and self (ego dissolution)
- Emotional lability: euphoria, anxiety, paranoia
- Mystical-type experiences
Influencing Factors
Dose, set (mindset), and setting (environment) critically shape the experience. Effects last 4–6 hours.
Therapeutic Research
Clinical trials show promise for treatment-resistant depression, end-of-life anxiety, PTSD, and substance use disorders. However, psilocybin carries risks:
- Psychological distress ("bad trips")
- Exacerbation of underlying psychotic disorders
- Cardiovascular stimulation (hypertension, tachycardia)
- Legal status: Schedule I in many countries
Use only in controlled, professional settings with proper screening and support.
Brain Tumors - Related Articles
- Understanding Right Middle Lobe Pacification on Chest X-rays
- Bumps on Back of Head: Causes, Evaluation, and Treatment
- Understanding Brain Cysts: Causes, Symptoms & Treatment Options
- Metastatic Brain Tumors: Causes, Symptoms & Treatment Options
- Understanding a 1.7 cm Adrenal Adenoma: What to Expect
- Meningioma Symptoms: Understanding Signs & Symptoms
- Glioblastoma: Causes, Risk Factors & Treatment Challenges